Access, Prevention Key to Reducing Preterm Birth
Lowering infant mortality rates begins with reducing preterm births, a recent briefing on Capitol Hill conveyed.
Do Profits – or Patients – Benefit from 340B Growth?
Under the Affordable Care Act, fewer Americans are now uninsured. So why does the government’s discount drug problem for hospitals treating uninsured patients continue to expand?
Comprehensive Medication Management: Collaborating for Better Care, Lower Costs
Getting patients’ medications right could save $290 million in avoidable medical spending, Terry McInnis, MD explained in a recent Patient Advocacy Leaders Summit webinar.
Perinatal Providers Stand by FDA Indication in New RSV Prevention Guidelines
The National Perinatal Association’s 2015 guidelines for preventative RSV (respiratory syncytial virus) treatment send a clear message about protecting pre-term infants: the FDA indication stands.
New IfPA Policy Brief Examines Abuse-deterrent Pain Medications
Abuse-deterrent formulations mark a valuable step toward curbing prescription pain pill abuse, suggests a new Institute for Patient Access policy brief.
Panel Explores Value, Challenges of Clinical Trial Participation
Participating in a clinical trial offers patients unprecedented access to investigative treatments – and an unparalleled opportunity to give back to society.
Do Clinical Pathways Inhibit Cancer Care?
Clinical pathways could be the route to less transparent, more restricted cancer care.
New Campaign Touts Novel Cancer Therapies
A new campaign is raising public awareness about a different way to fight cancer –immuno-oncology, or I-O therapies.
What “Meaningful Difference” Means for Medicare Patient Access
It’s Medicare open enrollment time for America’s seniors.
Nonprofits Promote Rx Storage, Safety and Synchronization
Millions of children now grow up in homes headed by grandparents – who may not store their prescription medications out of children’s reach.
